Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 3
1974 2
1979 1
1981 2
1982 1
1984 1
1985 1
1986 2
1987 4
1988 4
1990 2
1991 1
1992 4
1993 6
1994 2
1995 1
1998 2
1999 5
2000 7
2001 4
2002 7
2003 23
2004 14
2005 11
2006 12
2007 8
2008 11
2009 16
2010 16
2011 12
2012 10
2013 20
2014 15
2015 13
2016 14
2017 18
2018 13
2019 20
2020 34
2021 40
2022 37
2023 31
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).
Kato K, Doki Y, Ogata T, Motoyama S, Kawakami H, Ueno M, Kojima T, Shirakawa Y, Okada M, Ishihara R, Kubota Y, Amaya-Chanaga C, Chen T, Matsumura Y, Kitagawa Y. Kato K, et al. Among authors: shirakawa y. Esophagus. 2023 Apr;20(2):291-301. doi: 10.1007/s10388-022-00970-1. Epub 2022 Nov 19. Esophagus. 2023. PMID: 36401133 Free PMC article. Clinical Trial.
[High-dose insulin therapy].
Shirakawa Y. Shirakawa Y. Chudoku Kenkyu. 2012 Sep;25(3):201-4. Chudoku Kenkyu. 2012. PMID: 23057396 Review. Japanese. No abstract available.
HSP90 and its inhibitors.
Hao H, Naomoto Y, Bao X, Watanabe N, Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Takaoka M. Hao H, et al. Among authors: shirakawa y. Oncol Rep. 2010 Jun;23(6):1483-92. doi: 10.3892/or_00000787. Oncol Rep. 2010. PMID: 20428801 Review.
Lessons learned from health education in Japanese schools.
Tomokawa S, Shirakawa Y, Miyake K, Ueno M, Koiso T, Asakura T. Tomokawa S, et al. Among authors: shirakawa y. Pediatr Int. 2021 Jun;63(6):619-630. doi: 10.1111/ped.14637. Epub 2021 May 25. Pediatr Int. 2021. PMID: 33544412 Review.
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Nishiwaki N, Noma K, Ohara T, Kunitomo T, Kawasaki K, Akai M, Kobayashi T, Narusaka T, Kashima H, Sato H, Komoto S, Kato T, Maeda N, Kikuchi S, Tanabe S, Tazawa H, Shirakawa Y, Fujiwara T. Nishiwaki N, et al. Among authors: shirakawa y. Cancer Immunol Immunother. 2023 Jul;72(7):2029-2044. doi: 10.1007/s00262-023-03378-7. Epub 2023 Feb 10. Cancer Immunol Immunother. 2023. PMID: 36764954 Free PMC article.
Autophagy: Can it become a potential therapeutic target?
Bao XH, Naomoto Y, Hao HF, Watanabe N, Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Takaoka M. Bao XH, et al. Among authors: shirakawa y. Int J Mol Med. 2010 Apr;25(4):493-503. doi: 10.3892/ijmm_00000369. Int J Mol Med. 2010. PMID: 20198296 Review.
413 results